Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DIETARY SUPPLEMENT Cause Folliculitis? 177 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 177 reports of Folliculitis have been filed in association with DIETARY SUPPLEMENT. This represents 9.0% of all adverse event reports for DIETARY SUPPLEMENT.

177
Reports of Folliculitis with DIETARY SUPPLEMENT
9.0%
of all DIETARY SUPPLEMENT reports
158
Deaths
162
Hospitalizations

How Dangerous Is Folliculitis From DIETARY SUPPLEMENT?

Of the 177 reports, 158 (89.3%) resulted in death, 162 (91.5%) required hospitalization, and 172 (97.2%) were considered life-threatening.

Is Folliculitis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DIETARY SUPPLEMENT. However, 177 reports have been filed with the FAERS database.

What Other Side Effects Does DIETARY SUPPLEMENT Cause?

Off label use (363) Dyspnoea (357) Headache (349) Drug ineffective (347) Hypertension (328) Vomiting (322) Fatigue (312) Nausea (306) Condition aggravated (300) General physical health deterioration (290)

What Other Drugs Cause Folliculitis?

METHOTREXATE (4,146) LEFLUNOMIDE (4,022) ABATACEPT (3,977) TOCILIZUMAB (3,951) CERTOLIZUMAB PEGOL (3,781) GOLIMUMAB (3,675) ADALIMUMAB (3,572) ACETAMINOPHEN (3,522) RITUXIMAB (3,481) CHLORHEXIDINE (3,405)

Which DIETARY SUPPLEMENT Alternatives Have Lower Folliculitis Risk?

DIETARY SUPPLEMENT vs DIETARY SUPPLEMENT\HERBALS DIETARY SUPPLEMENT vs DIETARY SUPPLEMENT\MINERALS\VITAMINS DIETARY SUPPLEMENT vs DIETARY SUPPLEMENT\UBIDECARENONE DIETARY SUPPLEMENT vs DIFELIKEFALIN DIETARY SUPPLEMENT vs DIFLUNISAL

Related Pages

DIETARY SUPPLEMENT Full Profile All Folliculitis Reports All Drugs Causing Folliculitis DIETARY SUPPLEMENT Demographics